. But producing and supplying billions of doses remain major concerns as the fast-spreading respiratory illness overwhelms health care systems around the world.“We will continue to collaborate globally to ensure sufficient worldwide supply,” Gilead chief executive officer Daniel O’Day said in aTwo major Indian drugmakers – Hetero Labs and Cipla Ltd – on Sunday gained approval to begin selling their generic versions of remdesivir in the country.
Gilead said an inhaled formulation of the drug would be given through a nebulizer, which could potentially allow for easier use outside hospitals.
Flunked its ebola vaccine trials, teetering with investors, till raised from the dead...drug touted by Trump.
Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite: